Drugmaker Nostrum and CEO

MO 2026 Healthcare General

OIG False Claims

Penalty

$50 million

Outcome

OIG enforcement action against Drugmaker Nostrum and CEO for false claims. Penalty: $50 million.

Details

Drugmaker Nostrum and CEO — OIG Enforcement (2026)

OIG took enforcement action against Drugmaker Nostrum and CEO in MO in 2026 involving false claims violations in the Healthcare General sector.

Penalty: $50 million

Violation types: False Claims
Entity type: Healthcare Provider
Penalty type: Settlement
Location: MO

Source: Drugmaker Nostrum and CEO Agree to Pay Up to $50 Million to Resolve Claims of Underpaying Rebates Owed Under Medicaid Drug Rebate Program

How Crucible Prevents This

Crucible's billing compliance controls enforce documentation-to-claims reconciliation, requiring clinical attestation before claims submission and flagging billing patterns that deviate from documented care delivery.

Source: Drugmaker Nostrum and CEO Agree to Pay Up to $50 Million to Resolve Claims of Underpaying Rebates Owed Under Medicaid Drug Rebate Program

Don't let this happen to your organization. See how Crucible works.

See How Crucible Works